$FENC

Fennec Pharmaceuticals Inc.

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Research Triangle Park, NC

FENC chart

What traders are saying about $FENC

Latest posts

Fennec Pharmaceuticals Inc. news

Fennec Pharmaceuticals Inc. key financials

USD2025202420232022
Revenue$44.6M$47.5M$21.3M$1.5M
Net income-$9.74B-$436.0M-$16.05B-$23.7M
Diluted EPS$-0.34$-0.02$-0.60$-0.90
Total assets (year end)$70.6M$44.9M$26.9M$26.9M
Cash and equivalents (year end)$36.8M$26.6M$13.3M$23.8M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Fennec Pharmaceuticals Inc.

Ticker
FENC (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Research Triangle Park, NC
Incorporated in
British Columbia, Canada
Fiscal year end
December 31
SEC CIK
1211583
Former names
ADHEREX TECHNOLOGIES INC

Frequently asked questions

What exchange is Fennec Pharmaceuticals Inc. listed on?

Fennec Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol FENC.

What industry is Fennec Pharmaceuticals Inc. in?

Fennec Pharmaceuticals Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Fennec Pharmaceuticals Inc. headquartered?

Fennec Pharmaceuticals Inc.'s business address on file with the SEC is in Research Triangle Park, NC.

When does Fennec Pharmaceuticals Inc.'s fiscal year end?

Fennec Pharmaceuticals Inc.'s fiscal year ends on December 31.

How much revenue did Fennec Pharmaceuticals Inc. report?

Fennec Pharmaceuticals Inc. reported $44.6M in revenue for calendar year 2025, according to its SEC filings.